{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:06:10Z","timestamp":1784531170260,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["IK6 BX005386"],"award-info":[{"award-number":["IK6 BX005386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["AI125770"],"award-info":[{"award-number":["AI125770"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6 BX005386"],"award-info":[{"award-number":["IK6 BX005386"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119653","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:28:45Z","timestamp":1781245725000},"page":"119653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer"],"prefix":"10.1016","volume":"201","author":[{"given":"Marinaldo Pac\u00edfico","family":"Cavalcanti-Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f4nica Soares","family":"Brauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Rella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3686-5850","authenticated-orcid":false,"given":"Achraf","family":"Shamseddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deveney","family":"Dasilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8806-6212","authenticated-orcid":false,"given":"Gabriel Soares","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivea Pereira","family":"de Sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-0778","authenticated-orcid":false,"given":"Kenneth","family":"Shroyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3349-3369","authenticated-orcid":false,"given":"Yusuf","family":"Hannun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-3120","authenticated-orcid":false,"given":"Maurizio","family":"Del Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119653_bib1","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2026.119653_bib2","unstructured":"Breast Cancer Facts & Figures 2024-2025. American Cancer Society \u3008<\u3009\u3008https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/2024\/breast-cancer-facts-and-figures-2024.pdf\u3009\u3008>\u3009."},{"key":"10.1016\/j.biopha.2026.119653_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2026.119653_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107223","article-title":"Antineoplastic drugs inducing cardiac and vascular toxicity - an update","volume":"153","author":"Barachini","year":"2023","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119653_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/TGR.0000000000000212","article-title":"Antineoplastic therapy side effects and polypharmacy in older adults with cancer","volume":"35","author":"Stout","year":"2019","journal-title":"Top. Geriatr. Rehabil."},{"key":"10.1016\/j.biopha.2026.119653_bib6","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2026.119653_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119653_bib8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119653_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108488","article-title":"Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): an updated review","volume":"249","author":"Dong","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119653_bib10","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1158\/1078-0432.CCR-11-1590","article-title":"Molecular pathways: regulation and therapeutic implications of multidrug resistance","volume":"18","author":"Chen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119653_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5732\/cjc.011.10315","article-title":"Reversing multidrug resistance by tyrosine kinase inhibitors","volume":"31","author":"He","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119653_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.plipres.2010.02.001","article-title":"The functions of steryl glycosides come to those who wait: recent advances in plants, fungi, bacteria and animals","volume":"49","author":"Grille","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biopha.2026.119653_bib13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ejlt.201200033","article-title":"Steryl glycosides and acylated steryl glycosides in plant foods reflect unique sterol patterns","volume":"114","author":"Nystrom","year":"2012","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.biopha.2026.119653_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.plipres.2015.11.003","article-title":"Plasma membrane lipids and their role in fungal virulence","volume":"61","author":"Rella","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biopha.2026.119653_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jof8111130","article-title":"Sterylglucosides in Fungi","volume":"8","author":"Pereira de Sa","year":"2022","journal-title":"J. Fungi"},{"key":"10.1016\/j.biopha.2026.119653_bib16","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1042\/BCJ20200532","article-title":"Structure, metabolism and biological functions of steryl glycosides in mammals","volume":"477","author":"Shimamura","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2026.119653_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02909-18","article-title":"Cryptococcus neoformans glucuronoxylomannan and sterylglucoside are required for host protection in an animal vaccination model","volume":"10","author":"Colombo","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.biopha.2026.119653_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3892\/ol.2024.14719","article-title":"Steroidal saponins: natural compounds with the potential to reverse tumor drug resistance (Review)","volume":"28","author":"Cui","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2026.119653_bib19","first-page":"159","article-title":"Assessment of Antitumor Activity of \u03b2-sitosterol-\u03b2-D-glucoside Isolated and Identified from Justicia brandegeana","volume":"11","author":"Shehawy","year":"2022","journal-title":"Int. J. Nutr. Food Sci."},{"key":"10.1016\/j.biopha.2026.119653_bib20","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1021\/acs.jafc.8b03305","article-title":"Anti-breast-cancer activity exerted by beta-sitosterol-d-glucoside from sweet potato via upregulation of MicroRNA-10a and via the PI3K-Akt signaling pathway","volume":"66","author":"Xu","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2026.119653_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cbdd.12830","article-title":"An enzymatic approach to configurationally rare trans-androsteronyl-alpha-glucoside and Its potential anticancer application","volume":"89","author":"Chou","year":"2017","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.biopha.2026.119653_bib22","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1039\/C9CC09415F","article-title":"Pregnenolonyl-alpha-glucoside exhibits marked anti-cancer and CYP17A1 enzymatic inhibitory activities","volume":"56","author":"Chou","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biopha.2026.119653_bib23","doi-asserted-by":"crossref","first-page":"31466","DOI":"10.18632\/oncotarget.8965","article-title":"Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119653_bib24","first-page":"432","article-title":"Fluorescence-based assays for measuring doxorubicin in biological systems","volume":"2","author":"Kauffman","year":"2016","journal-title":"React. Oxyg. Species"},{"key":"10.1016\/j.biopha.2026.119653_bib25","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1074\/jbc.M111.312157","article-title":"Different modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells","volume":"287","author":"Pasquier","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119653_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119653_bib27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.biopha.2026.119653_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105079","article-title":"A novel synergistic anticancer effect of fungal cholestanol glucoside and paclitaxel: apoptosis induced by an intrinsic pathway through ROS generation in cervical cancer cell line (HeLa)","volume":"72","author":"Subramaniam","year":"2021","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.biopha.2026.119653_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112358","article-title":"Steroidal glycosides from Convallaria majalis whole plants and their cytotoxic activity","volume":"18","author":"Matsuo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119653_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119653_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1248\/bpb.21.741","article-title":"Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models","volume":"21","author":"Shimizu","year":"1998","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2026.119653_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0168-3659(01)00411-4","article-title":"Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells","volume":"75","author":"Maitani","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119653_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/md17110597","article-title":"Modulation of doxorubicin intracellular accumulation and anticancer activity by triterpene glycoside cucumarioside A(2)-2","volume":"17","author":"Menchinskaya","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.biopha.2026.119653_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.926975","article-title":"Molecular mechanism of beta-sitosterol and its derivatives in tumor progression","volume":"12","author":"Bao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119653_bib35","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1038\/s41598-021-84492-3","article-title":"Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer","volume":"11","author":"De Vita","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119653_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1039\/C9BM01766F","article-title":"Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma","volume":"8","author":"Molinaro","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119653_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2026.119653_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600689X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600689X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:41:56Z","timestamp":1784529716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600689X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S075333222600689X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119653","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119653"}}